- Comprehensive Management in Patients with Type 2 Diabetes Mellitus
-
Kim SK
- KMID: 2458966
- J Korean Diabetes.
- 2019 Sep;20(3):170-175.
- doi: 10.4093/jkd.2019.20.3.170
Management of patients with diabetes mellitus should not be restricted to the treatment of hyperglycemia and diabetic complications. An integrated comprehensive approach is needed for successful management, which should include... -
- CITED
-
- Close
- SHARE
-
- Close
- Bariatric/Metabolic Surgery and Type 2 Diabetes
-
Kim JH
- KMID: 2458962
- J Korean Diabetes.
- 2019 Sep;20(3):136-141.
- doi: 10.4093/jkd.2019.20.3.136
When type 2 diabetes and obesity occur together, disease burden is increased and this is an important public health concern due to the deleterious effects. Despite continuing advances in pharmacological... -
- CITED
-
- Close
- SHARE
-
- Close
- Care Tips for Self-Care among Older Diabetic Patients
-
Yoo B
- KMID: 2458969
- J Korean Diabetes.
- 2019 Sep;20(3):190-193.
- doi: 10.4093/jkd.2019.20.3.190
With the increase in the elderly population, the number of elderly diabetics is also increasing rapidly. To educate older people with diabetes, we need to understand their characteristics and those... -
- CITED
-
- Close
- SHARE
-
- Close
- Risk Factors Management in Diabetic Patients
-
Kim SY
- KMID: 2458965
- J Korean Diabetes.
- 2019 Sep;20(3):157-169.
- doi: 10.4093/jkd.2019.20.3.157
Diabetes mellitus is associated with a high frequency of complications related to cardiovascular disease as well as microvascular complications such as nephropathy, retinopathy, and neuropathy. Prevention of these vascular complications... -
- CITED
-
- Close
- SHARE
-
- Close
- Coaching for Self-Management of Diabetes in Medical Nutrition Therapy
-
Cho JW
- KMID: 2458968
- J Korean Diabetes.
- 2019 Sep;20(3):181-189.
- doi: 10.4093/jkd.2019.20.3.181
From the early stage of diabetes diagnosis, it may necessary to modify lifestyle including nutrition and physical activity. Self-management instruction and support can result in healthy eating habits for effective... -
- CITED
-
- Close
- SHARE
-
- Close
- Self-Care of Diabetic Nephropathy
-
Shin UJ
- KMID: 2458967
- J Korean Diabetes.
- 2019 Sep;20(3):176-180.
- doi: 10.4093/jkd.2019.20.3.176
Early intervention in patients with diabetes may slow the progression of kidney disease, and early recognition of renal impairment is critical to achieving optimal patient outcomes. Annual screening for the... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effects of the 2030 Diabetes Camp Program on Depression, Anxiety, and Stress in Diabetic Patients
-
Jung JH, Lee JH, Camp Committee
- KMID: 2458970
- J Korean Diabetes.
- 2019 Sep;20(3):194-204.
- doi: 10.4093/jkd.2019.20.3.194
BACKGROUND: The purpose of this study was to evaluate the effects of the 2030 Diabetes Camp program on depression, anxiety, and stress among diabetic patients. METHODS: This study enrolled diabetic patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Injectable Therapy for Diabetes Mellitus: Glucagon-Like Peptide-1 Receptor Agonist
-
Lee I, Kang ES
- KMID: 2458964
- J Korean Diabetes.
- 2019 Sep;20(3):149-156.
- doi: 10.4093/jkd.2019.20.3.149
According to the American Diabetes Association (ADA) and the European Association for the Study of Diabetes guideline for treatment of diabetes, glucagon-like peptide-1 receptor agonist (GLP-1 RA) is recommended in... -
- CITED
-
- Close
- SHARE
-
- Close
- Oral Hypoglycemic Agents for Patients with Type 2 Diabetes Mellitus
-
Ko SH
- KMID: 2458963
- J Korean Diabetes.
- 2019 Sep;20(3):142-148.
- doi: 10.4093/jkd.2019.20.3.142
For patients with newly diagnosed type 2 diabetes mellitus (T2DM), lifestyle modifications including medical nutrition therapy, weight control, physical activity, smoking cessation, and avoidance of alcohol abuse should be initiated.... -
- CITED
-
- Close
- SHARE
-
- Close
- Safety Issues with Sodium-Glucose Cotransporter 2 Inhibitors: Clinical Considerations
-
Lim S
- KMID: 2458961
- J Korean Diabetes.
- 2019 Sep;20(3):127-135.
- doi: 10.4093/jkd.2019.20.3.127
Diabetes mellitus (DM) is linked to poor outcomes after cardiovascular events and renal complications. Recently, novel antidiabetic agents, such as dipeptidyl peptidase-4 inhibitors, sodium-glucose cotransporter 2 (SGLT2) inhibitors, and glucagon-like... -
- CITED
-
- Close
- SHARE
-
- Close
